
Physician-level medication adherence is a strong predictor of patient health and should be considered as a measure of physician quality.
Physician-level medication adherence is a strong predictor of patient health and should be considered as a measure of physician quality.
The offer of free medications to low-income Medicare beneficiaries with diabetes enrolled in Part D plans has no impact on generic prescribing rates.
Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
This study evaluates the prevalence, structure, and key features of pharmacy-based programs to synchronize prescription fill dates, about which, little is known.
This study examines the association between plan-level measures of health outcomes and medication adherence to assess the viability of adherence as a measure of plan performance.
Published: July 9th 2015 | Updated:
Published: March 17th 2016 | Updated:
Published: March 17th 2017 | Updated:
Published: June 26th 2017 | Updated:
Published: February 11th 2019 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.